Re: Biomedical Publications Profile and Trends in Gulf Cooperation Council Countries

od Mikhailidis, Dimitri P
Izdano 2012

Epicardial fat: a novel marker of subclinical atherosclerosis in clinical practice?

od Katsiki, Niki, Mikhailidis, Dimitri P.
Izdano u Anatol J Cardiol (2017)

Hyperuricaemia in Cardiovascular Diseases: A Passive or an Active Player?

od Katsiki, Niki, Mikhailidis, Dimitri P.
Izdano u Med Princ Pract (2015)

Endocan and Erectile Dysfunction

od Balta, Sevket, Mikhailidis, Dimitri P.
Izdano u Am J Mens Health (2019)

Perivascular adipose tissue in cardiovascular diseases

od Katsiki, Niki, Mikhailidis, Dimitri P.
Izdano u Anatol J Cardiol (2020)

Diabetes and carotid artery disease: a narrative review

od Katsiki, Niki, Mikhailidis, Dimitri P.
Izdano u Ann Transl Med (2020)

Ciprofibrato na prevenção primária : controle das hiperlipidemias.

od Lewis, Barry, Mikhailidis, Dimitri P.
Izdano 1998.

Patient with Hypertriglyceridemia, Type 2 Diabetes, and Chronic Kidney Disease Treated with Atorvastatin and Omega-3 Fatty Acid Ethyl Esters

od Athyros, Vasilios G, Mikhailidis, Dimitri P
Izdano 2012

Half a century and more of PhD theses by published papers: Comment on: “Bringing the doctoral thesis by published papers to the Social Sciences and the Humanities: A quantitative e...

od Breimer, Lars H., Mikhailidis, Dimitri P.
Izdano u Scientometrics (2020)

Obstructive sleep apnea and cardiovascular disease: Is mean platelet volume one of the links?

od Papanas, Nikolaos, Mikhailidis, Dimitri P., Steiropoulos, Paschalis
Izdano u Anatol J Cardiol (2016)

Leptin, cardiovascular diseases and type 2 diabetes mellitus

od Katsiki, Niki, Mikhailidis, Dimitri P, Banach, Maciej
Izdano u Acta Pharmacol Sin (2018)

Is type 2 diabetes mellitus a coronary heart disease equivalent or not? Do not just enjoy the debate and forget the patient!

od Katsiki, Niki, Banach, Maciej, Mikhailidis, Dimitri P.
Izdano u Arch Med Sci (2019)

Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic

od Katsiki, Niki, Banach, Maciej, Mikhailidis, Dimitri P.
Izdano u Arch Med Sci (2020)

CETP inhibition in the REVEAL trial: could we aim higher?

od Sahebkar, Amirhossein, Mikhailidis, Dimitri P., Banach, Maciej
Izdano u Arch Med Sci (2020)

More Good News on Statins and COVID-19

od Katsiki, Niki, Banach, Maciej, Mikhailidis, Dimitri P
Izdano u Am J Cardiol (2021)

Assessing renal function – searching for the perfect marker continues!

od Nair, Devaki R., Mehta, Shweta, Mikhailidis, Dimitri P.
Izdano 2011

Estimated Glomerular Filtration rate (eGFR): A Serum Creatinine-Based Test for the Detection of Chronic Kidney Disease and its Impact on Clinical Practice

od Jain, Anjly, Mikhailidis, Dimitri P., Nair, Devaki R.
Izdano 2012

Dysfunctional high-density lipoprotein: not only quantity but first of all quality?

od Agouridis, Aris P., Banach, Maciej, Mikhailidis, Dimitri P.
Izdano u Arch Med Sci (2015)

A Comparison of the Aldosterone‐blocking Agents Eplerenone and Spironolactone

od Karagiannis, Asterios, Athyros, Vasilios G., Mikhailidis, Dimitri P.
Izdano u Clin Cardiol (2009)

The Link Between Human and Transgenic Animal Studies Involving Postprandial Hypertriglyceridemia and CETP Gene Polymorphisms

od Kolovou, Genovefa D, Anagnostopoulou, Katherine K, Mikhailidis, Dimitri P
Izdano 2009